Autolus Therapeutics (AUTL) Net Cash Flow Growth (1y) (2018 - 2025)
Autolus Therapeutics (AUTL) Net Cash Flow Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn | 53.46% |
| 10 | Autolus Therapeutics | 391.22 Mn | 90.51 Mn | -1.04 Mn | 104.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.45% |
| Sep 30, 2025 | 60.38% |
| Jun 30, 2025 | 141.42% |
| Mar 31, 2025 | -125.96% |
| Dec 31, 2024 | -1,389.39% |
| Sep 30, 2024 | -106.67% |
| Jun 30, 2024 | -26.31% |
| Mar 31, 2024 | 1,213.57% |
| Dec 31, 2023 | -112.62% |
| Sep 30, 2023 | -7.99% |
| Jun 30, 2023 | -27.83% |
| Mar 31, 2023 | -30.53% |
| Dec 31, 2022 | 52.42% |
| Sep 30, 2022 | 0.62% |
| Jun 30, 2022 | -36.14% |
| Mar 31, 2022 | -142.58% |
| Dec 31, 2021 | 516.56% |
| Sep 30, 2021 | 9.89% |
| Jun 30, 2021 | 17.43% |
| Mar 31, 2021 | 76.49% |